| abstract |
Disclosed are novel 1-aziridino-1-hydroxyiminomethyl derivatives of general formula (I), wherein R represents any organic group which can covalently bond to two aziridinoxim groups, R1 and R2 independently represent a hydrogen atom or a CH3, -C2H5, -CN, -COOH, -COOCH3, -COOC2H5, -CONH2 or -C6H5 group, and n stands for a whole number 2. The invention also relates to a method for the production of said compounds and pharmaceutical products containing said compounds. The compounds of general formula (I) have an anti-tumoral effect. |